Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AstraZeneca claims 11beta-HSD1 inhibitors for diabetes, obesity, etc.

May 12, 2004

Clinical benefits of pramlintide in the treatment of diabetes

May 12, 2004

Eisai and Abbott amend Japanese agreement for KES-524

May 11, 2004

Symbollon acquires safety data from Mimetix

May 11, 2004

Sumitomo discontinues SMP-140

May 11, 2004

Ilex presents HMG-CoA reductase lowering agents and their use in bone disorders

May 11, 2004

Antisense therapy for growth hormone disorders

May 11, 2004

Inhaled insulin reported more effective than other therapies for type 2 diabetes

May 10, 2004

Salsalate shows promise as a novel drug for type 2 diabetes

May 10, 2004

Adiponectin reduces body weight in mice by increasing metabolic rate without reducing food intake

May 10, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...